"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
- Patient Information:
Details with Side Effects
Systemic consequences associated with overdosage of MAGNEVIST Injection have not been reported.
MAGNEVIST is contraindicated in patients with:
- Chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
- Acute kidney injury.
Last reviewed on RxList: 4/11/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Magnevist Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.